BCR-ABL tyrosine kinase inhibitors in the treatment of Philadelphia chromosome positive chronic myeloid leukemia: A review
To access this article, please choose from the options below
PII: S0145-2126(10)00236-5
doi:10.1016/j.leukres.2010.04.016
© 2010 Elsevier Ltd. All rights reserved.
